Endo International plc (ENDP) financial statements (2021 and earlier)

Company profile

Business Address MINERVA HOUSE, SIMMONSCOURT ROAD
DUBLIN 4, 00000
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments1,2131,6801,7801,5321,4551,5261,447
Cash and cash equivalents1,2131,6801,7801,5321,4551,5261,447
Restricted cash and investments172163181201247222308
Receivables575539339632516457481
Inventory, net of allowances, customer advances and progress billings352355331325328339336
Inventory352355331325328339336
Contract with customer, asset331  47
Other undisclosed current assets9864554741101177
Total current assets:2,4132,8032,6862,7352,5862,6492,755
Noncurrent Assets
Inventory, Noncurrent13      
Finance lease, right-of-use asset48      
Operating lease, right-of-use asset37394849525456
Property, plant and equipment 488490492505501495
Intangible assets, net (including goodwill)6,3015,7395,8415,9426,1666,5546,691
Goodwill3,5603,5603,5603,5603,5953,6153,616
Intangible assets, net (excluding goodwill)2,7412,1792,2812,3822,5712,9383,076
Deferred income tax assets22202  
Other noncurrent assets53959886787777
Other undisclosed noncurrent assets398      
Total noncurrent assets:6,8516,3626,4796,5716,8037,1867,319
TOTAL ASSETS:9,2659,1659,1659,3069,3909,83510,074
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:836868756855900937931
Accounts payable9410511388102110120
Accrued liabilities108117118150146172171
Employee-related liabilities1301126260807255
Taxes payable 2242114
Interest and dividends payable9813557100113101114
Other undisclosed accounts payable and accrued liabilities405397405452457471467
Deferred revenue1311123
Debt40404051515052
Other undisclosed current liabilities376379425439508678849
Total current liabilities:1,2541,2911,2221,3471,4601,6681,836
Noncurrent Liabilities
Long-term debt and lease obligation8,3198,3278,3458,4008,4088,4168,422
Long-term debt, excluding current maturities8,2818,2868,3038,3558,3608,3658,370
Operating lease, liability38404345485152
Liabilities, other than long-term debt340330312297388404407
Deferred income tax liabilities26272827323233
Other liabilities314303284270356372373
Total noncurrent liabilities:8,6598,6578,6588,6978,7968,8208,829
Total liabilities:9,9139,9489,88010,04410,25610,48710,665
Stockholders' equity
Stockholders' equity attributable to parent, including:(648)(782)(715)(738)(867)(661)(590)
Common stock0000000
Additional paid in capital8,9388,9308,9258,9188,9058,8958,884
Accumulated other comprehensive loss(218)(225)(228)(234)(219)(223)(220)
Accumulated deficit(9,368)(9,488)(9,412)(9,422)(9,552)(9,334)(9,254)
Other undisclosed stockholders' equity attributable to parent0000000
Total stockholders' equity:(648)(782)(715)(738)(867)(661)(590)
Other undisclosed liabilities and equity     9 
TOTAL LIABILITIES AND EQUITY:9,2659,1659,1659,3069,3909,83510,074

Income statement (P&L) ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Revenues760635688820765729700
Cost of revenue(370)(348)(336)(389)(400)(389)(388)
Gross profit:391287351432365340312
Operating expenses(762)(223)(201)(291)(1,072)(211)(272)
Operating income (loss):(371)64150140(707)12940
Nonoperating income (expense)(4)74144(16)1
Foreign currency transaction gain (loss), before tax(4)(1)(3)6(1)(1)(2)
Other nonoperating income (expense)04001(17)0
Interest and debt expense(135)(136)(129)(133)(2)(0)(0)
Income (loss) from continuing operations before equity method investments, income taxes:(511)(65)2521(705)11340
Income (loss) from equity method investments2   (2)  
Other undisclosed income (loss) from continuing operations before income taxes500   483(137)(134)
Income (loss) from continuing operations before income taxes:(8)(65)2521(225)(24)(95)
Income tax expense (benefit)149(4)(8)13616(17)(3)
Income (loss) before gain (loss) on sale of properties:141(69)18158(208)(41)(98)
Other undisclosed net loss(64)   (62)  
Net income (loss):78(69)18158(271)(41)(98)
Other undisclosed net income (loss) attributable to parent42(7)(7)(28)52(38)(8)
Net income (loss) available to common stockholders, diluted:119(76)11130(219)(79)(106)

Comprehensive Income ($ in millions)

12/31/2020
Q4
9/30/2020
Q3
6/30/2020
Q2
3/31/2020
Q1
12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
Net income (loss):78(69)18158(271)(41)(98)
Comprehensive income (loss):78(69)18158(271)(41)(98)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent49(4)(1)(42)55(40)(4)
Comprehensive income (loss), net of tax, attributable to parent:127(73)16115(215)(82)(102)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: